<!doctype html>
<html>
<head>
<meta charset="UTF-8">
<meta name="apple-mobile-web-app-capable" content="yes">
<meta name="viewport" content="width=device-width initial-scale=1, user-scalable=no">
<meta name="apple-mobile-web-app-title" content="AstraZeneca | LYNPARZA">
<title>AstraZeneca | LYNPARZA</title>
<link rel="stylesheet" type="text/css" href="css/animate.min.css" />
<link rel="stylesheet" type="text/css" href="css/style.css" />
<script src="http://ajax.googleapis.com/ajax/libs/jquery/1.9.1/jquery.min.js"></script>
<style type="text/css">

.feature {width:824px; height:380px; margin-top: 100px; background-image: url('./img/moderatesevere_graph.png'); background-size: 100% auto;
background-repeat: no-repeat;
}
.footText {margin-top: 10px; font-family: "HelveticaLightCn"; line-height: 16px; font-size: 12px; color: #506061;}

ul { list-style: none; }

#container {
    background: white;   
}

header > p{padding-top: 35px; padding-left: 100px; font-family: lexiRegular; color: white; font-size: 30px; line-height: 32px;}
header > strong {padding-left: 100px; font-family: lexiRegular; color: white; font-size: 22px; line-height: 32px;}
header > sup {font-family: lexiRegular; color: white; font-size: 15px;}

.content p{color: #506061;/*font-family: "helveticaRoman"; margin-bottom:25px;*/}
.content p strong { color: #4f5656; font-family: "helveticaBold";}

.content > h1 {padding-top: 125px; font-family: lexiRegular; color: white; font-size: 55px; line-height: 55px; margin-bottom: 35px;}
.content > h3 {font-size: 25px; color: white;}
.content > span {background-image: url('../img/AZ_Logo.png'); background-repeat: no-repeat; width:240px; height:80px; position: absolute; margin-top: 200px;
margin-left: 500px;}

    .footnote { font-size:14px; line-height:16px; color: #506061;font-family: "HelveticaLightCn"; margin-top:45px; width: 840px;
    letter-spacing: -0.01em;}

.controls {position: absolute;}
.controls { width:36px; left:14px; top:205px; z-index:21; }
    .controls > li {font-family: "lexiRegular"; width:30px; height:30px; 
    border:1px solid #3F4344; -webkit-border-radius:500px; color:#3F4344; text-align:center; font-size:18px; line-height:32px; margin-bottom:40px;  }

    
.bodyContent {margin-top:111px; margin-left:68px; width:888px; height:555px; background-color: #003665; }
.bodyContent > li {font-family: "lexiRegular"; font-size: 24px; line-height: 30px; color: white; margin-bottom: 16px; padding-left: 38px;
padding-right: 29px; }
ul {list-style: none;}
.bodyContent > li:first-child {padding-top:69px;}
.bodyContent > li:nth-child(3) { margin-bottom: 26px; }

.bodyContent > ul:nth-child(4) {padding-left: 38px; color: white;}
.bodyContent > ul:nth-child(4) { font-size:14px; font-family: "HelveticaLightCn";  line-height: 16px;}
.bodyContent > ul:nth-child(4) > li:nth-child(4), .bodyContent > ul:nth-child(4) > li:nth-child(5) {margin-left: 15px;}


.close > p { font-family:"proximaBold"; font-size:30px; color: white; margin-left: 4px; margin-top: 4px;}
.logo, #popup, .controls, .popup .ref, .close, .inner-close, .bull li:before, .note, .info { position:absolute; }
.close, .inner-close { right: 15px; top: 15px; width:30px; height:30px; /*background: url('../img/close.png') 0 0 no-repeat;*/ border:1px solid #fff; -webkit-border-radius:100px; z-index:10;  }

    .contents > .close, .inner-close { border-color:#787878; background-position-y:-23px; display:none; }
    .video .close { background:#1b3e58; }
    
.nav .close { background:none; top:-50px; right:8px; }
    .nav .close:before { color:#004d74; }
.close, .inner-close, .logo, .info, .bull li:before { background-size:100% auto; }


#popup {
    height: 100%;
    width: 0;
    position: fixed;
    z-index: 1;
    top: 0;
    left: 0;

    background-color: rgba(0,0,0, 0.8);
    overflow-x: hidden;
    /*transition: 0.5s;*/
}

/*.sideText{
    width:282px;
    height:266px;
    position: absolute;
    margin-top: -350px;
}
.sideText > li {font-family: "HelveticaNeueLTStd"; font-size:11px; color: #3A4242;}
.sideText > li:first-child {margin-left: 133px; font-size: 10px; margin-top:3px;}

.sideText > li:nth-child(2) {margin-left: 60px; margin-top:1px; font-size: 12px;}
*/
</style> 

</head>
<body>

	<section id="container">
	<header>
		<p>Moderate-to-severe exacerbations for patients<br />who experienced an exacerbation in the past year</p>
         <strong>Network meta-analysis results for treatments compared with placebo</strong><sup>1</sup>
	</header>
        <ul class="controls">
            <li class="r">R</li>
            <li class="s">S</li>
        </ul>
    	<article class="content">

            <div class="feature"></div>

           <!--<ul class="sideText">
                <li>(tiotropium+budesonide/formoterol)</li>
                <li>(indacterol/glycopyrronium bromide)</li>
                <li></li>
                <li></li>
                <li></li>
                <li></li>
                <li></li>
                <li></li>
                <li></li>
                <li></li>
                <li></li>
                <li></li>
            </ul>-->
            <p class="footnote">Reference: 1. Tricco AC <em>et al. BMJ Open</em> 2015;5:e009183. Comparative safety and effectiveness of long-acting inhaled agents for treating chronic obstructive pulmonary
            <br />disease: A systematic review and network meta-analysis.</p>


        </article>

    <div id="popup">
        <span class="close"><p>X</p></span>
        <ul class="bodyContent">
            <li>A systematic review and network meta-analysis funded by the Canadian government* set out to answer the question: “What is the comparative effectiveness and safety of long-acting inhaled agents (ICS, LABA, LAMA) alone or in any combination for patients with COPD?”<sup>#</sup></li>
            <li>More than 200 RCTs in 134,692 patients were reviewed in one of the most comprehensive systematic reviews published to date.</li>
            <li>The results from 20 RCTs of at least 12 weeks duration in 26,141 patients showed that Spiriva<sup>®</sup>/Symbicort<sup>®</sup> (triple therapy) was associated with the 
                highest probability of reducing the risk of moderate-to-severe exacerbations 
                for patients who experienced an exacerbation in the last year.<sup>1#</sup> </li>
            <ul>
                <li>*Ontario Ministry of Health and Long-Term Care Health System Research Fund</li>
                <li>RCT = randomised controlled trial.</li>
                <li># The authors highlighted several limitations of this analysis:</li>
                <li>– since the original literature search in Dec. 2013, 21 new trials were published; particularly evident for LAMA/LABA combinations.</li>
                <li>– many of the included RCTs were at high risk of bias, in terms of Cochrane risk-of-bias-criteria.</li>
            </ul>
        </ul>
    </div>
    </section>

<script type="text/javascript" src="js/jquery-1.11.0.min.js"></script>
<script type="text/javascript" src="js/touchy.js"></script>
<script type="text/javascript" src="js/script.js"></script>
<script type="text/javascript">
	$( function(){
        //$(".popup").css("display","none");
        $(".s").click(function(){
            //$("header").css("display","none");
           // $("article").css("display","none");


            //$(".popup").css("display","block");
            //$(".popup").css("background-color","rgba(0,0,0,0.80)");
            document.getElementById("popup").style.width = "1024px";
            document.getElementById("popup").style.height = "768px";
        });
        $(".r").click(function(){
            //If reference Button Clicked
        });
        $("span > p").click(function(){
            document.getElementById("popup").style.width = "0";
            document.getElementById("popup").style.height = "0";
        })

	});



</script>
</body>
</html>
